181 related articles for article (PubMed ID: 31147054)
1. Control of octreotide release from silk fibroin microspheres.
Gong H; Wang J; Zhang J; Wu J; Zheng Z; Xie X; Kaplan DL; Li G; Wang X
Mater Sci Eng C Mater Biol Appl; 2019 Sep; 102():820-828. PubMed ID: 31147054
[TBL] [Abstract][Full Text] [Related]
2. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
[TBL] [Abstract][Full Text] [Related]
3. Silk coatings on PLGA and alginate microspheres for protein delivery.
Wang X; Wenk E; Hu X; Castro GR; Meinel L; Wang X; Li C; Merkle H; Kaplan DL
Biomaterials; 2007 Oct; 28(28):4161-9. PubMed ID: 17583788
[TBL] [Abstract][Full Text] [Related]
4. Sustained-release delivery of octreotide from biodegradable polymeric microspheres.
Rhee YS; Sohn M; Woo BH; Thanoo BC; DeLuca PP; Mansour HM
AAPS PharmSciTech; 2011 Dec; 12(4):1293-301. PubMed ID: 21948321
[TBL] [Abstract][Full Text] [Related]
5. Physical-Chemical Characterization of Octreotide Encapsulated in Commercial Glucose-Star PLGA Microspheres.
Beig A; Feng L; Walker J; Ackermann R; Hong JKY; Li T; Wang Y; Qin B; Schwendeman SP
Mol Pharm; 2020 Nov; 17(11):4141-4151. PubMed ID: 32876463
[TBL] [Abstract][Full Text] [Related]
6. Minimizing the initial burst of octreotide acetate from glucose star PLGA microspheres prepared by the solvent evaporation method.
Beig A; Ackermann R; Wang Y; Schutzman R; Schwendeman SP
Int J Pharm; 2022 Aug; 624():121842. PubMed ID: 35609832
[TBL] [Abstract][Full Text] [Related]
7. Modification of Three-Phase Drug Release Mode of Octreotide PLGA Microspheres by Microsphere-Gel Composite System.
Wang T; Zhang C; Zhong W; Yang X; Wang A; Liang R
AAPS PharmSciTech; 2019 Jun; 20(6):228. PubMed ID: 31227940
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of genipin-cross-linked silk fibroin/chitosan sustained-release microspheres.
Zeng S; Ye M; Qiu J; Fang W; Rong M; Guo Z; Gao W
Drug Des Devel Ther; 2015; 9():2501-14. PubMed ID: 25999693
[TBL] [Abstract][Full Text] [Related]
9. Raloxifene-/raloxifene-poly(ethylene glycol) conjugate-loaded microspheres: A novel strategy for drug delivery to bone forming cells.
Kavas A; Keskin D; Altunbaş K; Tezcaner A
Int J Pharm; 2016 Aug; 510(1):168-83. PubMed ID: 27343363
[TBL] [Abstract][Full Text] [Related]
10. In vitro drug release and antibacterial activity evaluation of silk fibroin coated vancomycin hydrochloride loaded poly (lactic-co-glycolic acid) (PLGA) sustained release microspheres.
Li S; Shi X; Xu B; Wang J; Li P; Wang X; Lou J; Li Z; Yang C; Li S; Zhen P
J Biomater Appl; 2022 Apr; 36(9):1676-1688. PubMed ID: 35015589
[TBL] [Abstract][Full Text] [Related]
11. Pore change during degradation of octreotide acetate-loaded PLGA microspheres: The effect of polymer blends.
Wang T; Xue P; Wang A; Yin M; Han J; Tang S; Liang R
Eur J Pharm Sci; 2019 Oct; 138():104990. PubMed ID: 31302216
[TBL] [Abstract][Full Text] [Related]
12. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
[TBL] [Abstract][Full Text] [Related]
13. Tracking the effect of microspheres size on the drug release from a microsphere/sucrose acetate isobutyrate (SAIB) hybrid depot in vitro and in vivo.
Lin X; Wang J; Xu Y; Tang X; Chen J; Zhang Y; Zhang Y; Yang Z
Drug Dev Ind Pharm; 2016 Sep; 42(9):1455-65. PubMed ID: 26790718
[TBL] [Abstract][Full Text] [Related]
14. Silk fibroin spheres as a platform for controlled drug delivery.
Wenk E; Wandrey AJ; Merkle HP; Meinel L
J Control Release; 2008 Nov; 132(1):26-34. PubMed ID: 18761384
[TBL] [Abstract][Full Text] [Related]
15. Silk microspheres for encapsulation and controlled release.
Wang X; Wenk E; Matsumoto A; Meinel L; Li C; Kaplan DL
J Control Release; 2007 Feb; 117(3):360-70. PubMed ID: 17218036
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of silk fibroin hydrogel as injectable implants for sustained release of Risperidone.
Ebrahimi A; Sadrjavadi K; Hajialyani M; Shokoohinia Y; Fattahi A
Drug Dev Ind Pharm; 2018 Feb; 44(2):199-205. PubMed ID: 28956466
[TBL] [Abstract][Full Text] [Related]
17. Structural insights into pH-responsive drug release of self-assembling human serum albumin-silk fibroin nanocapsules.
Tallian C; Herrero-Rollett A; Stadler K; Vielnascher R; Wieland K; Weihs AM; Pellis A; Teuschl AH; Lendl B; Amenitsch H; Guebitz GM
Eur J Pharm Biopharm; 2018 Dec; 133():176-187. PubMed ID: 30291964
[TBL] [Abstract][Full Text] [Related]
18. Microsphere delivery of Risperidone as an alternative to combination therapy.
D'Souza S; Faraj J; DeLuca P
Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):631-9. PubMed ID: 23892159
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
20. Control of silk microsphere formation using polyethylene glycol (PEG).
Wu J; Zheng Z; Li G; Kaplan DL; Wang X
Acta Biomater; 2016 Jul; 39():156-168. PubMed ID: 27181879
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
